Somatic mutations of BRCA1 and BRCA2 were significantly associated with HRD in BRCA, OV, and BLCA, and lung squamous cell carcinoma (LUSC) (FDR < 0.002, Table 1). This evidence concerns the gene BRCA2 and squamous cell lung carcinoma.